Loading
Latest filing published 03 Jun 2011 for Talecris Biotherapeutics Holdings Corp..
No signal scores available.
Joel E. Abelson is a declared insider of Talecris Biotherapeutics Holdings Corp., with filings sourced from SEC (Form 4). The record holds 13 filings, for trades running from 30 September 2009 to 1 June 2011.
No open-market purchase appears, only 5 sales worth €3.5M. The rest of the record consists of 3 share grants and 4 option exercises. 2011 to date brings no purchases and 2 sales.
Most recently, on 3 June 2011, the filings show a transaction in Talecris Biotherapeutics Holdings Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations